Shandong Sanyuan Biotechnology Co Ltd
SZSE:301206
Net Margin
Shandong Sanyuan Biotechnology Co Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | CN |
| Market Cap | 5.9B CNY |
| Net Margin |
13%
|
| Country | JP |
| Market Cap | 53.2T JPY |
| Net Margin |
4%
|
| Country | CH |
| Market Cap | 253.3B CHF |
| Net Margin |
12%
|
| Country | US |
| Market Cap | 95.7B USD |
| Net Margin |
12%
|
| Country | US |
| Market Cap | 43.7B USD |
| Net Margin |
11%
|
| Country | US |
| Market Cap | 41.9B USD |
| Net Margin |
18%
|
| Country | FR |
| Market Cap | 38.5B EUR |
| Net Margin |
3%
|
| Country | US |
| Market Cap | 40.2B USD |
| Net Margin |
13%
|
| Country | CN |
| Market Cap | 254.9B CNY |
| Net Margin |
-5%
|
| Country | ZA |
| Market Cap | 32.1B Zac |
| Net Margin |
7%
|
| Country | CN |
| Market Cap | 211.3B CNY |
| Net Margin |
23%
|
Profitability Report
View the profitability report to see the full profitability analysis for Shandong Sanyuan Biotechnology Co Ltd.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Shandong Sanyuan Biotechnology Co Ltd's most recent financial statements, the company has Net Margin of 13.1%.
You don't have any saved screeners yet
